- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: (((tuberous OR cerebral OR brain OR tuberosa OR tuberose) AND sclerosis) OR TSC OR bourneville OR bournevilles OR epiloia OR epiloya OR (adenoma sebaceum)) AND (everolimus OR votubia OR rad001 OR rad001a OR (rad 001) OR (rad 001a) OR afinitor OR affinitor OR certican OR zortress OR (sdz rad)).
Displaying page 1 of 1.
EudraCT Number: 2016-002977-37 | Sponsor Protocol Number: CRAD001M2X02B | Start Date*: 2017-08-25 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: An open-label, multi-center long-term safety roll-over study in patients with tuberous sclerosis complex (TSC) and refractory seizures who are judged by the Investigator to benefit from continued t... | |||||||||||||
Medical condition: Refractory seizures associated with tuberous sclerosis complex | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) HU (Ongoing) ES (Completed) BE (Completed) FR (Completed) PL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003795-13 | Sponsor Protocol Number: CRAD001M2305 | Start Date*: 2014-12-10 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: Long-term follow-up study to monitor the growth and development of pediatric patients previously treated with everolimus in study CRAD001M2301 | |||||||||||||
Medical condition: Subependymal Giant Cell Astrocytoma (SEGA) associated with Tuberous Sclerosis Complex (TSC) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022583-13 | Sponsor Protocol Number: CRAD001MIC02 | Start Date*: Information not available in EudraCT |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: An open-label, multi-center, expanded access study of RAD001 in patients with subependymal giant cell astrocytomas (SEGA) associated with tuberous sclerosis complex (TSC). The EFFECTS STUDY: Everol... | ||
Medical condition: The study will evaluate the safety of RAD001 in patients with subependymal giant cell astrocytomas (SEGA) associated with Tuberous Sclerosis Complex (TSC). | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) ES (Completed) HU (Completed) CZ (Completed) FR (Ongoing) BE (Completed) GR (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-000860-90 | Sponsor Protocol Number: CRAD001M2304 | Start Date*: 2013-02-14 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A. | |||||||||||||
Full Title: A three-arm, randomized, double-blind, placebo-controlled study of the efficacy and safety of two trough-ranges of everolimus as adjunctive therapy in patients with tuberous sclerosis complex (TSC)... | |||||||||||||
Medical condition: Refractory partial-onset seizures associated with tuberous sclerosis complex (TSC) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Completed) NL (Completed) DE (Completed) HU (Completed) GB (Completed) BE (Completed) GR (Completed) DK (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006997-27 | Sponsor Protocol Number: CRAD001M2301 | Start Date*: 2011-06-01 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A randomized, double-blind, placebo-controlled study of RAD001 in the treatment of patients with subependymal giant cell astrocytomas (SEGA) associated with Tuberous Sclerosis Complex (TSC) | ||
Medical condition: This study will evaluate the antitumor activity of RAD001 versus placebo in patients with subependymal giant cell astrocytomas (SEGA) associated with Tuberous Sclerosis Complex (TSC). | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) IT (Completed) GB (Completed) DE (Completed) NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002531-18 | Sponsor Protocol Number: 69HCL16_0062 | Start Date*: 2018-10-31 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Topical Everolimus versus placebo for the treatment of facial angiofibromas in patients with tuberous sclerosis complex. A phase II/III, multicentre, randomized, double-blind, placebo-controlled st... | |||||||||||||
Medical condition: angiofibromas | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005397-63 | Sponsor Protocol Number: CRAD001MES12 | Start Date*: 2013-04-19 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A, | |||||||||||||
Full Title: An open-label, multi-center, expanded access study of RAD001 in patients with angiomyolipoma associated with tuberous sclerosis complex (TSC) | |||||||||||||
Medical condition: Angiomyolipoma associated with either Tuberous Sclerosis Complex (TSC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002113-48 | Sponsor Protocol Number: CRAD001M2302 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) | |||||||||||||
Medical condition: Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) NL (Completed) GB (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019519-39 | Sponsor Protocol Number: RAPIT | Start Date*: 2012-03-14 |
Sponsor Name:Erasmus MC - Department of Neurology | ||
Full Title: Efficacy of RAD001/everolimus in Autism and NeuroPsychological deficits in children with TSC (RAPIT-trial) | ||
Medical condition: Tuberous Sclerosis Complex | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004854-25 | Sponsor Protocol Number: SPON803-10 | Start Date*: 2012-01-10 | |||||||||||
Sponsor Name:Cardiff University | |||||||||||||
Full Title: TRON: A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis. | |||||||||||||
Medical condition: Tuberous Sclerosis Complex (TSC) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019825-32 | Sponsor Protocol Number: CRAD001X2201 | Start Date*: 2010-07-28 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: An exploratory, open label, non-randomized, within-patient multiple dose-escalation safety, tolerability, PK and efficacy trial of RAD001 (everolimus) in patients with Lymphangioleiomyomatosis. | |||||||||||||
Medical condition: Lymphangioleiomyomatosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.